目的 探索供體血輸入同種大鼠對誘導胰腺移植耐受的可能性。方法 用雄性Wistar大鼠作為實驗的供受體,胰腺移植當天取供體大鼠全血1 ml,注入糖尿病受體大鼠腹腔,輔以短期的硫唑嘌呤(Aza)。 結果 移植胰腺功能存活時間為28~112天(平均64.2天),與單純用硫唑嘌呤組(10.2天)或單純輸入供體血液組(9.8天)相比,移植胰腺功能存活時間顯著延長(P<0.01)。
結論 移植前短期使用免疫抑制劑以及移植當天輸入供體血液,能延長大鼠移植胰腺功能存活時間。
引用本文: 孫治君,姚榛祥. 輸入供體血對延長大鼠移植胰腺功能存活的初步研究. 中國普外基礎與臨床雜志, 2001, 8(6): 364-366. doi: 復制
版權信息: ?四川大學華西醫(yī)院華西期刊社《中國普外基礎與臨床雜志》版權所有,未經(jīng)授權不得轉載、改編
1. | Bushell A, Morris PJ, Wood KJ. Induction of operational tolerance by random blood transfusion combined with antiCD4 antibody therapy 〔J〕. Transplantation, 1994; 58(2)∶ 133. |
2. | Vogt P, Hiller WFA, Steiniger B, et al. Differential response of kidney and pancreas rejection to cyclosporine immunosuppression 〔J〕. Transplantation, 1992; 53(6)∶ 1269. |
3. | Klempnauer J, Vogt P, Hiller WFA. Donorspecific tolerance induced by nonmajor histocompatibility complex disparate kidney grafts for subsequent pancreas transplants 〔J〕. Transplant Pro, 1993; 25(1)∶373. |
4. | Tchervenkdv JI, Cofer BR, Davies C, et al. Indefinite allograft survival induced by the combination of multiple donorspecific transfusions, cyclosporine, and an antiT cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation 〔J〕. Transplantation, 1995; 59(6)∶821. |
5. | Takiff H, Novak M, Iwaki Y, et al. Lowdose cyclosporine maintenance therapy after immunosupressive induction in a rat cardiac transplant model 〔J〕. Transplantation, 1988; 45(2)∶297. |
6. | 畢愛華.免疫應答(二)免疫耐受.見: 畢愛華主編.醫(yī)學免疫學 〔M〕. 第1版. 北京: 人民軍醫(yī)出版社, 1995∶123~129. |
7. | Bayle F, Masson D, Zaoul P, et al. Beneficial effect of one HLA haplo or semiidentical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients 〔J〕. Transplantation, 1995; 59(5)∶719. |
8. | Flye MW, Burton K, Mohanakumar T, et al. Donorspecific transfusions have longterm beneficial effects for human renal allografts 〔J〕. Transplantation, 1995; 60(12)∶1395. |
9. | Van Twuvver E, Mooijaart RJD, Ten Berge IJM, et al. Pretransplantation blood transfusion revisited 〔J〕. N Eng J Med, 1991; 325(17)∶1210. |
10. | Brunson M, Tchervenkov JI, Alexander JW, et al. Enhancement of allograft survival by donorspecific transfusion one day prior to transplant 〔J〕. Transplantation, 1991; 52(4)∶ 543. |
11. | Levy AE, Alexander JW. Administration of intragraft interleukin4 prolongs cardiac allograft survival in rats treated with donorspecific transfusion/cyclosporine 〔J〕. Transplantation, 1995; 60(5)∶405. |
- 1. Bushell A, Morris PJ, Wood KJ. Induction of operational tolerance by random blood transfusion combined with antiCD4 antibody therapy 〔J〕. Transplantation, 1994; 58(2)∶ 133.
- 2. Vogt P, Hiller WFA, Steiniger B, et al. Differential response of kidney and pancreas rejection to cyclosporine immunosuppression 〔J〕. Transplantation, 1992; 53(6)∶ 1269.
- 3. Klempnauer J, Vogt P, Hiller WFA. Donorspecific tolerance induced by nonmajor histocompatibility complex disparate kidney grafts for subsequent pancreas transplants 〔J〕. Transplant Pro, 1993; 25(1)∶373.
- 4. Tchervenkdv JI, Cofer BR, Davies C, et al. Indefinite allograft survival induced by the combination of multiple donorspecific transfusions, cyclosporine, and an antiT cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation 〔J〕. Transplantation, 1995; 59(6)∶821.
- 5. Takiff H, Novak M, Iwaki Y, et al. Lowdose cyclosporine maintenance therapy after immunosupressive induction in a rat cardiac transplant model 〔J〕. Transplantation, 1988; 45(2)∶297.
- 6. 畢愛華.免疫應答(二)免疫耐受.見: 畢愛華主編.醫(yī)學免疫學 〔M〕. 第1版. 北京: 人民軍醫(yī)出版社, 1995∶123~129.
- 7. Bayle F, Masson D, Zaoul P, et al. Beneficial effect of one HLA haplo or semiidentical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients 〔J〕. Transplantation, 1995; 59(5)∶719.
- 8. Flye MW, Burton K, Mohanakumar T, et al. Donorspecific transfusions have longterm beneficial effects for human renal allografts 〔J〕. Transplantation, 1995; 60(12)∶1395.
- 9. Van Twuvver E, Mooijaart RJD, Ten Berge IJM, et al. Pretransplantation blood transfusion revisited 〔J〕. N Eng J Med, 1991; 325(17)∶1210.
- 10. Brunson M, Tchervenkov JI, Alexander JW, et al. Enhancement of allograft survival by donorspecific transfusion one day prior to transplant 〔J〕. Transplantation, 1991; 52(4)∶ 543.
- 11. Levy AE, Alexander JW. Administration of intragraft interleukin4 prolongs cardiac allograft survival in rats treated with donorspecific transfusion/cyclosporine 〔J〕. Transplantation, 1995; 60(5)∶405.